Cargando…
m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia
BACKGROUND: N6-methyladenosine (m6A) has been confirmed to function critically in acute myeloid leukemia (AML) progression. Hitherto, the subtyping and prognostic predictive significance of m6A-correlated genes in AML is unclear. METHOD: From The Cancer Genome Atlas (TCGA-LAML), Therapeutically Appl...
Autores principales: | Fu, Caizhu, Kou, Ruirui, Meng, Jie, Jiang, Duanfeng, Zhong, Ruilan, Dong, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436408/ https://www.ncbi.nlm.nih.gov/pubmed/37596597 http://dx.doi.org/10.1186/s12920-023-01629-1 |
Ejemplares similares
-
PRICKLE1, a Wnt/PCP signaling component, is overexpressed and associated with inferior prognosis in acute myeloid leukemia
por: Jiang, Duanfeng, et al.
Publicado: (2021) -
Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia
por: Jin, Peng, et al.
Publicado: (2020) -
Acute myeloid leukemia: leukemia stem cells write a prognostic signature
por: Gudgin, Emma J, et al.
Publicado: (2011) -
Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia
por: Zhong, Fangmin, et al.
Publicado: (2023) -
A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients
por: Wang, Fangce, et al.
Publicado: (2018)